Published Date: 16 Feb 2023
Chatbots have shields to control misinformation, but it will continue to be a game.
Read Full NewsIn a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?
New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.
A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.
A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.
A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.
1.
Report provides global picture of wide inequalities in care for women's cancers
2.
HER3 Antibody Drug Conjugate Shows Promise in NSCLC
3.
Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?
4.
The Cherenkov color image shows the possibility of improving the quality of radiation therapy.
5.
From 40 to 74, the US Preventive Services Task Force advises every two years for screening mammography.
1.
The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025
2.
Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential
3.
Unlocking the Mystery of Basilar Artery Stroke: A New Approach to Treatment
4.
Epigenetics and Resistance: Mechanisms in Histone Methylation-Targeted Therapies
5.
The latest Hematocrit: An Overview of Red Blood Cell Health
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part V
2.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
3.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
4.
Thromboprophylaxis In Medical Settings- An Update
5.
Navigating the Complexities of Ph Negative ALL - Part XII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation